Literature DB >> 2579725

The role of radiation therapy in the management of the non-Hodgkin's lymphomas.

R T Hoppe.   

Abstract

Radiation therapy has a broad range of applications in the management of patients with non-Hodgkin's lymphoma. It has curative potential for patients with Stage I to II low-grade lymphoma (small lymphocytic, follicular small cleaved, and follicular mixed) and has substantial palliative efficacy in patients with more advanced stage low-grade lymphoma. Low-dose whole-body irradiation may be used as palliative therapy even in patients with bone marrow involvement by these lymphomas. In the management of the large cell lymphomas (diffuse large cell, diffuse mixed, and immunoblastic), radiation alone has curative potential in only the most favorable early-stage presentations. However, since radiation can achieve significant responses in these tumors, it should be considered for inclusion in combined-modality programs. Reports that have appeared in the literature as well as results of treatment at Stanford that bear upon these issues are reviewed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579725     DOI: 10.1002/1097-0142(19850501)55:9+<2176::aid-cncr2820551421>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Current guidelines for the management of aggressive non-Hodgkin's lymphoma.

Authors:  M Martelli; V De Sanctis; G Avvisati; F Mandelli
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 2.  [Value of radiotherapy in disseminated high-grade non-Hodgkin's lymphoma].

Authors:  U Kaiser; R Pfab; K Havemann
Journal:  Strahlenther Onkol       Date:  1997-03       Impact factor: 3.621

3.  Long-term follow-up of CHOP-treated non-Hodgkin lymphoma of high-grade malignancy.

Authors:  R Heinz
Journal:  Blut       Date:  1990-02

4.  Reproducibility of irregular radiation fields for malignant lymphoma.

Authors:  U Mock; K Dieckmann; A M Molitor; U Haverkamp; R Pötter
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

5.  CHOP-VP16 chemotherapy and involved field irradiation for high grade non-Hodgkin's lymphomas: a phase II multicentre study.

Authors:  H Köppler; K H Pflüger; I Eschenbach; R Pfab; K Lennert; W Wellens; M Schmidt; W D Gassel; T Kolb; R Hässler
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

6.  Primary malignant lymphoma of the appendix.

Authors:  R J Stewart; M Mirakhur
Journal:  Ulster Med J       Date:  1986-10

7.  Involved field radiotherapy or chemotherapy in the management of stage I nodal intermediate grade non-Hodgkin's lymphoma.

Authors:  G M Jeffery; G M Mead; J M Whitehouse; R D Ryall
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.